ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Parmax Pharma Ltd will hold its 32nd Annual General Meeting on September 29, 2026. The meeting will address the adoption of financial statements and director appointments.
Parmax Pharma Ltd held its 2nd EGM on July 2, 2026, to approve capital restructuring. Key resolutions included increasing authorized share capital and issuing preferential equity and warrants.
Parmax Pharma convened an EGM for July 02, 2026, to approve a ₹19.28 Crore preferential issue. The move supports working capital and general corporate purposes.
Parmax Pharma Limited filed the scrutinizer's report for its Extra Ordinary General Meeting held on May 27, 2025. Shareholders approved key director appointments and re-appointments via remote e-voting.
Parmax Pharma Limited has scheduled an Extra Ordinary General Meeting on May 27, 2026. Key agenda items include the appointment of three non-executive directors and the re-appointment of Mr. Umang Gosalia as Managing Director for five years. Remote e-voting is available from May 24 to May 26, 2026.